Asymmetry Capital Management 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
AERIE PHARMACEUTICALS INC	COM	00771V108	1,710	140,587	SH		SOLE		140,587	0	0
AMICUS THERAPEUTICS INC	COM	03152W109	2,818	333,513	SH		SOLE		333,513	0	0
ANACOR PHARMACEUTICALS INC	COM	032420101	473	8,850	SH		SOLE		8,850	0	0
BIO-RAD LABRATORIES	COM	90572207	1,647	12,050	SH		SOLE		12,050	0	0
CENTENE CORP	COM	15135B101	730	11,850	SH		SOLE		11,850	0	0
QUEST DIAGNOSTICS INC	COM	74834L100	4,544	63,595	SH		SOLE		63,595	0	0
EDWARDS LIFESCIENCES CORP	COM	28176E108	1,392	15,780	SH		SOLE		15,780	0	0
IMPAX LABORATORIES INC	COM	45256B101	1,987	62,050	SH		SOLE		62,050	0	0
ELI LILLY & CO	COM	532457108	4,709	65,400	SH		SOLE		65,400	0	0
NEUROCRINE BIOSCIENCES INC	COM	64125C109	2,499	63,188	SH		SOLE		63,188	0	0
NEVRO CORP	COM	64157F103	2,778	49,377	SH		SOLE		49,377	0	0
ORASURE TECHNOLOGIES INC	COM	68554V108	500	69,200	SH		SOLE		69,200	0	0
QUIDEL CORP	COM	74838J101	717	41,550	SH		SOLE		41,550	0	0
TEVA PHARMACEUTICAL-SP ADR	ADR	881624209	2,209	41,286	SH		SOLE		41,286	0	0
UNITEDHEALTH GROUP INC	COM	91324P102	2,307	17,900	SH		SOLE		17,900	0	0
XENOPORT INC	COM	98411C100	7,340	1,627,628	SH		SOLE		1,627,628	0	0